A phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective Na V 1.8 inhibitor, in healthy male adults
A detailed assessment of tirzepatides tolerability and safety in a Japanese cohort, which included 443 participants, revealed that the frequency of TEAE was notably higher in the 15 mg group compared to the 5 mg and 10 mg groups
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906
A diagram of clinical practice recommendations for patients taking GLP-1 receptor agonists and dual GLP-1 and GIP receptor co-agonists before anaesthesia or sedation for surgical and endoscopic procedures is included with the updated recommendations and guidance (see Figure 1)
No, BPC-157 is not a growth hormone peptide
Non-Stimulant Lipotropic Formula This B12-free version is ideal for isolating the function of the main lipotropics without interference
